-
181
Interdependence of coagulation with immunotherapy and BRAF/MEK inhibitor therapy: results from a prospective study
Published 2024-11-01Subjects: “…Immune checkpoint inhibitors…”
Get full text
Article -
182
Fusobacterium nucleatum upregulates the immune inhibitory receptor PD-L1 in colorectal cancer cells via the activation of ALPK1
Published 2025-12-01Subjects: Get full text
Article -
183
The characteristics of the tumor immune microenvironment in colorectal cancer with different MSI status and current therapeutic strategies
Published 2025-01-01Subjects: Get full text
Article -
184
The clinical significance of T cell infiltration and immune checkpoint expression in central nervous system germ cell tumors
Published 2025-01-01Subjects: Get full text
Article -
185
Efficacy of first-line chemotherapy combined with immunotherapy or anti-angiogenic therapy in advanced KRAS-mutant non-small cell lung cancer
Published 2025-03-01Subjects: Get full text
Article -
186
-
187
Prognostic value of systemic immune-inflammation index in patients with small-cell lung cancer treated with immune checkpoint inhibitors
Published 2025-01-01Subjects: Get full text
Article -
188
Exploring the role of metabolic pathways in TNBC immunotherapy: insights from single-cell and spatial transcriptomics
Published 2025-01-01Subjects: Get full text
Article -
189
Assessing hemorrhagic risks in combination therapy: implications of angiogenesis inhibitors and immune checkpoint inhibitors
Published 2025-02-01Subjects: “…immune checkpoint inhibitors…”
Get full text
Article -
190
DNA methylation and immune evasion in triple-negative breast cancer: challenges and therapeutic opportunities
Published 2025-02-01Subjects: Get full text
Article -
191
Macrophages facilitate tumor cell PD‐L1 expression via an IL‐1β‐centered loop to attenuate immune checkpoint blockade
Published 2023-04-01Subjects: “…immune checkpoint blockade…”
Get full text
Article -
192
-
193
Hidradenitis suppurativa induced by ipilimumab and nivolumab: A rare association
Published 2025-03-01Subjects: Get full text
Article -
194
Editorial: Tertiary lymphoid structures (TLS) in the tumor immune microenvironment
Published 2025-01-01Subjects: Get full text
Article -
195
Pathological Complete Response to a Single Dose of Pembrolizumab‐Based Chemoimmunotherapy for Squamous Cell Carcinoma of the Lung: A Case Report
Published 2025-01-01Subjects: “…immune checkpoint inhibitors…”
Get full text
Article -
196
Targeting NANOS1 in triple-negative breast cancer: synergistic effects of digoxin and PD-1 inhibitors in modulating the tumor immune microenvironment
Published 2025-01-01Subjects: “…immune checkpoint blockade…”
Get full text
Article -
197
-
198
Efficacy and safety of first-line nivolumab plus ipilimumab treatment in elderly patients (aged ≥ 75 years) with non-small cell lung cancer
Published 2025-01-01Subjects: Get full text
Article -
199
Biomarkers in metastatic castration-resistant prostate cancer for efficiency of immune checkpoint inhibitors
Published 2025-12-01Subjects: Get full text
Article -
200
Impacts of hyperthermic chemotherapeutic agent on cytotoxicity, chemoresistance-related proteins and PD-L1 expression in human gastric cancer cells
Published 2024-12-01Subjects: Get full text
Article